NovaBridge Biosciences (FRA:0VY)
Germany flag Germany · Delayed Price · Currency is EUR
1.630
+0.020 (1.24%)
At close: Aug 26, 2026

NovaBridge Biosciences Revenue

Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
30
Market Cap
186.18M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023632.00K2.18M-
Dec 31, 2022-1.55M-15.40M-
Dec 31, 202113.85M-222.30M-94.14%
Dec 31, 2020236.15M231.84M5,381.18%
Dec 31, 20194.31M-3.51M-44.90%
Dec 31, 20187.82M6.04M340.20%
Dec 31, 20171.78M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Biotest GmbH & Co. KGaA648.90M
Novogenia AG54.30M
Paion AG14.81M
MagForce AG1.08M
Biomark Diagnostics37.15K
co.don AG22.00K
bioXXmed AG16.73K
2invest AG-1.64M
Revenue Rankings